Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/9613
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKalyoncu, U.-
dc.contributor.authorSolmaz, D.-
dc.contributor.authorEmmungil, H.-
dc.contributor.authorYazici, A.-
dc.contributor.authorKasifoglu, T.-
dc.contributor.authorKimyon, G.-
dc.contributor.authorBalkarlı, Ayşe-
dc.date.accessioned2019-08-16T13:03:26Z
dc.date.available2019-08-16T13:03:26Z
dc.date.issued2016-
dc.identifier.issn0896-8411-
dc.identifier.urihttps://hdl.handle.net/11499/9613-
dc.identifier.urihttps://doi.org/10.1016/j.jaut.2016.02.010-
dc.description.abstractBackground: Adult-onset Still's disease (AOSD) is a rare condition, and treatment choices are frequently dependent on expert opinions. The objectives of the present study were to assess treatment modalities, disease course, and the factors influencing the outcome of patients with AOSD. Methods: A multicenter study was used to reach sufficient patient numbers. The diagnosis of AOSD was based on the Yamaguchi criteria. The data collected included patient age, gender, age at the time of diagnosis, delay time for the diagnosis, typical AOSD rash, arthralgia, arthritis, myalgia, sore throat, lymphadenopathy, hepatomegaly, splenomegaly, pleuritis, pericarditis, and other rare findings. The laboratory findings of the patients were also recorded. The drugs initiated after the establishment of a diagnosis and the induction of remission with the first treatment was recorded. Disease patterns and related factors were also investigated. A multivariate analysis was performed to assess the factors related to remission. Results: The initial data of 356 patients (210 females; 59%) from 19 centers were evaluated. The median age at onset was 32 (16-88) years, and the median follow-up time was 22 months (0-180). Fever (95.8%), arthralgia (94.9%), typical AOSD rash (66.9%), arthritis (64.6%), sore throat (63.5%), and myalgia (52.8%) were the most frequent clinical features. It was found that 254 of the 306 patients (83.0%) displayed remission with the initial treatment, including corticosteroids plus methotrexate with or without other disease-modifying antirheumatic drugs. The multivariate analysis revealed that the male sex, delayed diagnosis of more than 6 months, failure to achieve remission with initial treatment, and arthritis involving wrist/elbow joints were related to the chronic disease course. Conclusion: Induction of remission with initial treatment was achieved in the majority of AOSD patients. Failure to achieve remission with initial treatment as well as a delayed diagnosis implicated a chronic disease course in AOSD. © 2016 Elsevier Ltd.en_US
dc.language.isoenen_US
dc.publisherAcademic Pressen_US
dc.relation.ispartofJournal of Autoimmunityen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAdult-onset Still's diseaseen_US
dc.subjectDisease modifying anti-rheumatic drugsen_US
dc.subjectDisease patternen_US
dc.subjectRemissionen_US
dc.subjectcorticosteroiden_US
dc.subjectdisease modifying antirheumatic drugen_US
dc.subjecthydroxychloroquineen_US
dc.subjectmethotrexateen_US
dc.subjectantiinflammatory agenten_US
dc.subjectbiological markeren_US
dc.subjectadulten_US
dc.subjectadult onset Still diseaseen_US
dc.subjectarthralgiaen_US
dc.subjectarthritisen_US
dc.subjectArticleen_US
dc.subjectchronic diseaseen_US
dc.subjectclinical featureen_US
dc.subjectcohort analysisen_US
dc.subjectdelayed diagnosisen_US
dc.subjectdrug megadoseen_US
dc.subjectfemaleen_US
dc.subjectfeveren_US
dc.subjectfollow upen_US
dc.subjecthepatomegalyen_US
dc.subjecthumanen_US
dc.subjectlaboratory testen_US
dc.subjectlymphadenopathyen_US
dc.subjectmajor clinical studyen_US
dc.subjectmaleen_US
dc.subjectmedical record reviewen_US
dc.subjectmulticenter studyen_US
dc.subjectmyalgiaen_US
dc.subjectonset ageen_US
dc.subjectoutcome assessmenten_US
dc.subjectpericarditisen_US
dc.subjectpleurisyen_US
dc.subjectpriority journalen_US
dc.subjectrashen_US
dc.subjectremissionen_US
dc.subjectsore throaten_US
dc.subjectsplenomegalyen_US
dc.subjecttreatment failureen_US
dc.subjecttreatment responseen_US
dc.subjectadolescenten_US
dc.subjectageden_US
dc.subjectclinical trialen_US
dc.subjectcombination drug therapyen_US
dc.subjectmiddle ageden_US
dc.subjectphenotypeen_US
dc.subjectrecurrent diseaseen_US
dc.subjectrisk factoren_US
dc.subjectStill's Disease, Adult-Onseten_US
dc.subjecttreatment outcomeen_US
dc.subjectvery elderlyen_US
dc.subjectyoung adulten_US
dc.subjectAdolescenten_US
dc.subjectAdulten_US
dc.subjectAgeden_US
dc.subjectAged, 80 and overen_US
dc.subjectAnti-Inflammatory Agentsen_US
dc.subjectBiomarkersen_US
dc.subjectDelayed Diagnosisen_US
dc.subjectDrug Therapy, Combinationen_US
dc.subjectFemaleen_US
dc.subjectHumansen_US
dc.subjectMaleen_US
dc.subjectMiddle Ageden_US
dc.subjectPhenotypeen_US
dc.subjectRecurrenceen_US
dc.subjectRemission Inductionen_US
dc.subjectRisk Factorsen_US
dc.subjectTreatment Outcomeen_US
dc.subjectYoung Adulten_US
dc.titleResponse rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohorten_US
dc.typeArticleen_US
dc.identifier.volume69en_US
dc.identifier.startpage59
dc.identifier.startpage59en_US
dc.identifier.endpage63en_US
dc.identifier.doi10.1016/j.jaut.2016.02.010-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.pmid26970681en_US
dc.identifier.scopus2-s2.0-84960153857en_US
dc.identifier.wosWOS:000374919900006en_US
dc.identifier.scopusqualityQ1-
dc.ownerPamukkale University-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeArticle-
item.grantfulltextnone-
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

68
checked on Nov 16, 2024

WEB OF SCIENCETM
Citations

68
checked on Nov 21, 2024

Page view(s)

38
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.